IDYA vs. ELEV
Compare and contrast key facts about IDEAYA Biosciences, Inc. (IDYA) and Elevation Oncology Inc (ELEV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IDYA or ELEV.
Performance
IDYA vs. ELEV - Performance Comparison
Returns By Period
In the year-to-date period, IDYA achieves a -24.70% return, which is significantly lower than ELEV's 12.36% return.
IDYA
-24.70%
-9.19%
-28.96%
-15.22%
30.29%
N/A
ELEV
12.36%
0.47%
-84.29%
30.69%
N/A
N/A
Fundamentals
| IDYA | ELEV | |
|---|---|---|
| Market Cap | $2.24B | $34.29M |
| EPS | -$2.30 | -$0.80 |
| Total Revenue (TTM) | $3.92M | $58.00K |
| Gross Profit (TTM) | $720.00K | $29.00K |
| EBITDA (TTM) | -$223.50M | -$40.62M |
Key characteristics
| IDYA | ELEV | |
|---|---|---|
| Sharpe Ratio | -0.33 | 0.19 |
| Sortino Ratio | -0.18 | 1.81 |
| Omega Ratio | 0.98 | 1.26 |
| Calmar Ratio | -0.33 | 0.32 |
| Martin Ratio | -0.76 | 0.57 |
| Ulcer Index | 20.00% | 53.64% |
| Daily Std Dev | 46.07% | 164.08% |
| Max Drawdown | -74.64% | -97.64% |
| Current Drawdown | -43.16% | -96.25% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between IDYA and ELEV is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
IDYA vs. ELEV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Elevation Oncology Inc (ELEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IDYA vs. ELEV - Dividend Comparison
Neither IDYA nor ELEV has paid dividends to shareholders.
Drawdowns
IDYA vs. ELEV - Drawdown Comparison
The maximum IDYA drawdown since its inception was -74.64%, smaller than the maximum ELEV drawdown of -97.64%. Use the drawdown chart below to compare losses from any high point for IDYA and ELEV. For additional features, visit the drawdowns tool.
Volatility
IDYA vs. ELEV - Volatility Comparison
The current volatility for IDEAYA Biosciences, Inc. (IDYA) is 15.67%, while Elevation Oncology Inc (ELEV) has a volatility of 26.18%. This indicates that IDYA experiences smaller price fluctuations and is considered to be less risky than ELEV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
IDYA vs. ELEV - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Elevation Oncology Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities